Loading clinical trials...
Loading clinical trials...
A Phase 1 Study of Reolysin Alone in Patients With Relapsed or Refractory Multiple Myeloma
Conditions
Interventions
Diagnostic Laboratory Biomarker Analysis
Wild-type Reovirus
Locations
1
United States
Ohio State University Comprehensive Cancer Center
Columbus, Ohio, United States
Start Date
April 1, 2012
Primary Completion Date
February 1, 2015
Completion Date
February 1, 2015
Last Updated
April 15, 2015
NCT05312255
NCT03717844
NCT04508790
NCT04640779
NCT04850599
NCT04756401
Lead Sponsor
National Cancer Institute (NCI)
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions